HDAC6 inhibitor WT161 performs anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU

Background: WT161, as a selective HDAC6 inhibitor, has been shown to play anti-tumor effects on several kinds of cancers. The aim of the present study is to explore the roles of WT161 in osteosarcoma and its underlying mechanisms. Methods: The anti-proliferative effect of WT161 on osteosarcoma cells...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biosci Rep
Main Authors: Sun, Jun, Wu, Wei, Tang, Xiaofeng, Zhang, Feifei, Ju, Cheng, Liu, Renfeng, Liang, Yiping, Yu, Bo, Lv, Bin, Guo, Yuhong, Zeng, Duo, Tao, Xuchang, Wang, Min, Zhang, Zhiping, Zhang, Changhua, Lv, Xiao-Bin
Formato: Artigo
Idioma:Inglês
Publicado em: Portland Press Ltd. 2021
Assuntos:
Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8150159/
https://ncbi.nlm.nih.gov/pubmed/33860796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20203905
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados